GlassScriptPhysician profile
Sarah Hu
NPI 1528415460
$867.83
in general payments reported to CMS, 2019-2025
17 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $84.64 · 2022: $259 · 2023: $283 · 2024: $55.31 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $133.14 | 2022-2024 | |
| Medtronic, INC. | $123.98 | 2022-2023 | Minimed 780g, Mycarelink |
| Abbvie INC. | $105.60 | 2021-2025 | |
| Dexcom, INC. | $66.28 | 2021-2023 | Dexcom G6 Transmitter |
| Neurocrine Biosciences, INC. | $58.95 | 2025 | |
| Pfizer INC. | $56.15 | 2022-2025 | |
| Beta Bionics, INC. | $52.64 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Eton Pharmaceuticals, INC. | $48.67 | 2023-2025 | Alkindi, Khindivi, Increlex |
| Tolmar Pharmaceuticals, INC. | $38.14 | 2022 | |
| Biomarin Pharmaceutical INC. | $26.51 | 2022 | |
| Sequel Med Tech, LLC | $26.15 | 2025 | Twiist |
| Tandem Diabetes Care, INC. | $26.14 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Ultragenyx Pharmaceutical INC. | $24.46 | 2022 | |
| Novo Nordisk INC | $24.32 | 2023 | |
| Mannkind Corporation | $20.70 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $20.48 | 2022 | |
| Insulet Corporation | $15.52 | 2023 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.